图书馆主页
数据库简介
最新动态
联系我们



返回首页


 刊名字顺( Alphabetical List of Journals):

  A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL


  检 索:         高级检索

期刊名称:ANTIVIRAL CHEMISTRY & CHEMOTHERAPY

ISSN:0956-3202
版本:SCI-CDE
出版频率:Bimonthly
出版社:INT MEDICAL PRESS LTD, 2-4 IDOL LANE, LONDON, ENGLAND, EC3R 5DD
  出版社网址:http://www.intmedpress.com/index.cfm?pid=11
期刊网址:http://www.intmedpress.com/index.cfm?pid=12
影响因子:
主题范畴:VIROLOGY;    PHARMACOLOGY & PHARMACY

期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)   



About the journal

 

Now in its fourteenth year of publication, Antiviral Chemistry & Chemotherapy is a well-established primary journal devoted to all aspects of antiviral compounds from design, synthesis and mode of action to chemistry, pharmacology and virology. Major features of this journal are:

International journal

Expert and rapid peer review of submitted manuscripts.

Regular review articles of topical interest.

Highly respected Editorial Board.

Worldwide readership.

50 free offprints and no page charges.

The journal is covered by major indexing and abstracting services such as Index Medicus and Medline, Current Contents/Life Sciences, Research Alert, Chemical Abstracts, Science Citation Index, SciSearch, EMBASE/Exerpta Medica.
Antiviral Chemistry & Chemotherapy is an official publication of the International Society for Antiviral Research.

 


Instructions to Authors

 

International Medical Press would be pleased to hear from authors wishing to submit a manuscript to Antiviral Chemistry & Chemotherapy. The Journal will provide 25 offprints of your published article for free, and there are no page charges.

This page contains details on how to submit a manuscript to
Antiviral Chemistry & Chemotherapy:
* Online submission
* Copyright assignment
* Author guidelines

Before submitting your manuscript to Antiviral Chemistry & Chemotherapy, please ensure that the manuscript has been prepared in accordance with the Antiviral  Chemistry & Chemotherapy Author Guidelines.

Unsolicited Research Articles, Short Communications and Letters to the Editor are welcome at any time. Reviews are usually commissioned, but authors are invited to submit outlines of potential review articles for consideration. Manuscripts submitted to Antiviral Chemistry & Chemotherapy are considered for publication on the understanding that the work contained not submitted simultaneously to another journal in the English language.

Online manuscript submission
Authors can submit manuscripts online.
Clicking here will open a new browser window. Follow the instructions to submit your manuscript. Please ensure that all fields are filled. It is especially important that the correct E-mail address is added, because all correspondence, including confirmation of receipt, will be sent to this address. If you do not receive confirmation within a week of online submission, please contact us at info@intmedpress.com.

Five files can be uploaded. Please ensure that all files to be uploaded are in one of the following formats: Word document (.doc), Adobe portable document format (.pdf) or Powerpoint presentation (.ppt). If the manuscript contains higher resolution images, these can be submitted following peer-review if necessary.

Alternatively, authors can send three copies of each type-written, double-spaced manuscript to the relevant Section Editor - along with a disk containing electronic copies of all text, letters, figures and tables.

The Section Editors reserve the right to reject clearly unacceptable manuscripts in consultation with the Editor-in-Chief without further peer-review. Copies of related manuscripts submitted elsewhere or in press should accompany the submitted manuscript. All queries about submission of manuscripts should be addressed to the Editorial Office.

A detailed set of instructions for authors is given below. If you have any further queries concerning the submission of manuscripts, please contact any of the Editors or the
Editorial Office.

Antiviral Chemistry & Chemotherapy publishes the results of original research on all aspects of antiviral compounds and chemotherapy. Manuscripts concerned with the biochemistry, mode of action, pharmacology, synthesis and virology of antiviral agents will be welcomed, as well as animal model studies. Chemical papers may show negative antiviral effects providing the virological rationale for the synthesis of the compounds is clearly stated and a sound biological/virological methodology is described. The journal does not usually accept papers on general virology or vaccines.

Manuscripts will be published as Full Papers or Short Communications, which contain no more than two illustrations. Reviews, either short or comprehensive, are published regularly. Authors wishing to submit a review are encouraged to contact the Reviews Editor at an early stage. The journal will publish Letters to the Editor relating to previously published articles or other matters.

Submission of Manuscripts
Full papers must be divided into sections as follows: a Summary of up to 250 words that states the object of the study and the main findings, Introduction, Materials and Methods, Results, Discussion and References. The Summary should be clear and comprehensible in its own right for abstracting purposes. The Discussion should highlight the main findings and briefly discuss their significance in relation to previous work. (Reviews and Short Communications need not be subdivided, except that the Summary and References sections are required.) The title page should include the authors' names and addresses, and the corresponding author's phone and fax numbers and e-mail address. The title page should also carry a short running title of up to 50 characters and up to 6 key words for indexing purposes. Tables and Figure legends should follow the main text. Each Table should have a title; footnotes may be used to define headings and data as appropriate. Each Figure must be supplied with a title and an explicit legend.

Spellings should be English and follow those in the Concise Oxford Dictionary, and standard abbreviations should be as recommended in Units, Symbols and Abbreviations (The Royal Society of Medicine, 1994). Other abbreviations may be defined at first usage but should only be used for terms used frequently in the paper. A list of abbreviations may be provided for an entry below the keywords.

Three copies of the manuscript should be submitted either online (see above), direct to the Editor-in-Chief or to the Editorial Office:

Dr Hugh J Field, International Medical Press Ltd, 2-4 Idol Lane, London EC3R 5DD, UK; Tel: +44 1223 330 810; Fax: +44 1223 332 998; E-mail: hjf10@cam.ac.uk

or to the relevant Editor:

Professor Chris McGuigan, University of Wales Cardiff, Welsh School of Pharmacy, Redwood Building, King Edward VII Avenue, Cardiff CF10 3XF, UK; Tel: +44 29 2087 4537; Fax: +44 29 2087 4537; E-mail: Mcguigan@cardiff.ac.uk

Dr Michael Otto, AVCC, Rhone-Poulenc Rorer, 500 Arcola Road, CM6, PO Box 5096, Collegeville, PA 19426-0800, USA; Tel: +1 678 395 0047; Fax: +1 678 395 0030;
E-mail:
motto@pharmasset.com

Professor Robert W Sidwell, AVCC, Institute for Antiviral Research, Utah State University, Logan, UT 84322-5600, USA; Tel: +1 435 797 1902; Fax: +1 435 797 3959;
E-mail:
rsidwell@cc.usu.edu

Professor Masanori Baba, AVCC, Center for Chronic Viral Disease, Faculty of Medicine, Kagoshima University, Kagoshima 890, Japan; Tel: +81 99 275 5930;
Fax:+81 99 275 5932;
E-mail:
baba@med3.kufm.kagoshima-u.ac.jp

or to the Reviews Editor:

Dr John S Mills, Drector of Biology, Amedis Phamaceuticals Ltd, Unit 209 Cambridge Science Park, Milton Road, Cambridge, CB4 0GZ; Tel: +44 (0)1223 477915; Fax: +44 (0)1233 477911; E-mail john.mills@amedis-pharma.com

Papers will be assessed by anonymous reviewers and authors may, if they wish, recommend one or more names for use at the Editor's discretion. Every effort will be made to expedite the reviewing process and authors should normally expect to receive an editorial response within 6 weeks of submission.

Tables and Figures
One set of original drawings or photographs should be supplied with the top copy. Lettering, numbering and symbols in the Figures must be clear and suitable for reduction to single or double column width. Lettering and lines on graphs should also be suitable for reduction. Chemical schemes etc. should be supplied as standard figures and in all cases the figure must be accompanied by a title and a legend that describes the illustration. The figure number, author's name and top edge should be indicated on the reverse using a soft pencil. Colour figures are acceptable and are reproduced free-of-charge at the Editors' discretion.

References
The Harvard system should be used to cite references in the text; for papers with three or more authors, et al. should be used. An unpublished study may be referred to as a personal communication giving the name and short address, e.g. (D Brown, The London Hospital Medical College, personal communication). It is the author's responsibility to obtain permission from the colleague whose work is cited and to ensure that the information in all references is accurate. In the text, references should be inserted in parentheses, as follows: (Brown, 1994; Brown & Black, 1994; Brown et al., 1994) or ...as previously shown by Brown et al. (1994). Only references to articles in journals or books will be permitted. Meeting abstracts and patent applications may not be quoted unless they are published in a form that is available for library reference. The references should be listed at the end of the paper in alphabetical order according to the first named author. All authors' names and the full title of the paper must be supplied together with the year, volume, first and last pages, and full title of the journal. The following provide examples of reference style:

Naesens L, Snoeck R, Andrei G, Balzarini J, Neyts J & De Clercq E (1997) HPMC (cidofovir), PMEA (adefovir) and related acyclic nucleoside phosphonate analogues: a review of their pharmacology and clinical potential in the treatment of viral infections. Antiviral Chemistry & Chemotherapy 8:1?3.

Yang Y-W & Yang J-C (1997) Inhibitory effect of polyionic compounds on the adsorption of herpes simplex virus type (KOS). Antiviral Chemistry & Chemotherapy 8:32?7.

Purcell RH (1996) Hepatitis C virus. In Encyclopedia of Virology, vol. 2. Edited by RG Webster and A Granoff. London: Academic Press, pp. 569?73.

Nomenclature
For viruses, restriction endonucleases and other enzymes, authors should follow (as far as possible) established international practice. For drugs, where appropriate, the generic name or common synonyms should be given, particularly for less well known compounds.

Materials and Methods: Chemistry
Procedures used for the synthesis of novel compounds (where there is a specific antiviral rationale) together with spectral and analytical data establishing their structure and purity should be reported briefly in the Materials and Methods under the subheading Chemistry. Authors should be concise and whenever possible use a format that describes general reaction conditions (only once), tabulating experimental data to afford effective presentation and economical use of space. The title of an experiment should include the chemical name of the product (preferably IUPAC nomenclature) and a compound number. Additional analytical data required for refereeing may be deposited with the Editors as 'supplementary data'. Templates for chemical structure drawing are available at
http://www.cf.ac.uk/phrmy/ChemEd/AVCC.html

Materials and Methods: Virology
Quantitative biological data will be required on all 'target' compounds and the methods should be described under the subheading Virology. The names and brief addresses of suppliers of non-standard equipment and reagents should be provided.

Cover Photograph
The cover photograph normally reflects some aspect of a paper or review in that issue. The Editors are happy to discuss suggestions for the cover at any stage during the processing of a manuscript. A 16 cm?glossy colour print is required, accompanied by an explanatory caption to appear on the back cover.

Disk Submission
On acceptance of the manuscript, authors will be invited to supply a copy of the final version on disk. Further information on the choice of disk formats for text and figures will be provided at this time.

Proofs
Authors will be advised of the likely date for dispatch of proofs (usually within 8 weeks of acceptance) and these should be corrected and returned within 3 days. Only corrections and essential changes should be made and the cost of additional changes will be charged to the Authors. The Editors reserve the right to make minor modifications to the manuscripts. Material changes will be submitted to the Authors for approval at the proof stage.

Copyright
If accepted, papers become copyright of International Medical Press. Authors will be required to give signed consent to publication, but permission to use material elsewhere (for example in review articles) will normally be granted on request.

Ethical Matters
Authors must conform to current standards as regards the use of animals for experimental study and the normal requirements for obtaining consent from the relevant ethical committees for the conduct of clinical trials.

Offprints
Twenty-five offprints of each article will be supplied free of charge. Additional offprints may be ordered using a form and scale of charges supplied with the proofs.

Editorial Office
International Medical Press
2? Idol Lane
London EC3R 5DD
UK
Tel: +44 20 7398 0700
Fax: +44 20 7398 0701
E-mail:
info@intmedpress.com

 


Editorial Board

 

Editor-in-Chief

 

Reviews Editor

Hugh J Field
Centre for Veterinary Science
University of Cambridge
Madingley Road
Cambridge CB3 0ES
UK

John S Mills
Drector of Biology
Amedis Phamaceuticals Ltd
Unit 162 Cambridge Science Park
Milton Road
Cambridge
CB4 0GP

E-mail: john.mills@amedis-pharma.com

Chemistry Editor
Chris McGuigan
University of Wales Cardiff
Welsh School of Pharmacy
Redwood Building
King Edward VII Avenue
Cardiff CF10 3XF
UK

E-mail:
AVCC@cardiff.ac.uk



Editors
Masanori Baba
Center for Chronic Viral Disease
Faculty of Medicine
Kagoshima University
Kagoshima 890
Japan


Michael Otto
Pharmasset, Inc.
1860 Montreal Road
Tucker, GA 30084
USA

Robert W Sidwell
Institute for Antiviral Research
Utah State University
Logan, UT 84322-5600
USA


Editorial Board

J Balzarini, Belgium
KK Biron, USA
A Broom, USA
MS Chen, USA
J Colacino, USA
S Daluge, USA
D Dargan, UK
E De Clercq, Belgium
J Drach, USA
AK Field, USA
M Gait, UK
GJ Galasso, USA
P Griffiths, UK
P Herdewijn, Belgium
A Hol?I>, Czech Republic
ER Kern, USA
C Laughlin, USA
S Locarnini, Australia
J Martin, USA

 

A Matsuda, Japan
H Mitsuya, USA
T North, USA
B Öberg, Sweden
J Oxford, UK
KL Powell, UK
DD Richman, USA
R Schinazi, USA
JA Secrist III, USA
D Shugar, Poland
M Slater, UK
D Smee, USA
H Tanaka, Japan
S Tyms, UK
A-M Vandamme, Belgium
RJ Whitley, USA
J Zemlicka, USA


 返回页首 


邮编:430072   地址:中国武汉珞珈山   电话:027-87682740   管理员Email:
Copyright © 2005-2006 武汉大学图书馆版权所有